 Inhibikase Therapeutics, Inc. NASDAQ:IKT Q3 2022 Earnings Conference Call November 15, 2022 8:00 AM ET Company Participants Alex Lobo Stern Investor Relations Milton Werner President and Chief Executive Officer Conference Call Participants Operator Good day, and welcome to Inhibikase Therapeutics Third Quarter 2022 Financial Results Conference Call. All participants are in listen-only mode. 